These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 35462199)

  • 1. Multiscale modeling of the cellular uptake of C6 peptide-siRNA complexes.
    Purijjala PWCM; Rathnayake PVGM; Kumara BT; Gunathunge BCM; Ranasinghe RAAP; Karunaratne DN; Ranatunga RJKU
    Comput Biol Chem; 2022 Jun; 98():107679. PubMed ID: 35462199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. siRNA delivery using amphipathic cell-penetrating peptides into human hepatoma cells.
    Furukawa K; Tanaka M; Oba M
    Bioorg Med Chem; 2020 Apr; 28(8):115402. PubMed ID: 32146061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new amphipathic, amino-acid-pairing (AAP) peptide as siRNA delivery carrier: physicochemical characterization and in vitro uptake.
    Jafari M; Xu W; Naahidi S; Chen B; Chen P
    J Phys Chem B; 2012 Nov; 116(44):13183-91. PubMed ID: 23077976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Amphipathic Structure of a Dipropylglycine-Containing Helical Peptide with Sufficient Length Enables Safe and Effective Intracellular siRNA Delivery.
    Oba M; Shibuya M; Yamaberi Y; Yokoo H; Uchida S; Ueda A; Tanaka M
    Chem Pharm Bull (Tokyo); 2023; 71(3):250-256. PubMed ID: 36858531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of cationic and amphipathic cell penetrating peptides for siRNA delivery and efficacy.
    Mo RH; Zaro JL; Shen WC
    Mol Pharm; 2012 Feb; 9(2):299-309. PubMed ID: 22171592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peptide-ligand binding modeling of siRNA with cell-penetrating peptides.
    García-Sosa AT; Tulp I; Langel K; Langel Ü
    Biomed Res Int; 2014; 2014():257040. PubMed ID: 25147791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends in the Binding of Cell Penetrating Peptides to siRNA: A Molecular Docking Study.
    Rathnayake PV; Gunathunge BG; Wimalasiri PN; Karunaratne DN; Ranatunga RJ
    J Biophys; 2017; 2017():1059216. PubMed ID: 28321253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimisation of vectorisation property: A comparative study for a secondary amphipathic peptide.
    Konate K; Lindberg MF; Vaissiere A; Jourdan C; Aldrian G; Margeat E; Deshayes S; Boisguerin P
    Int J Pharm; 2016 Jul; 509(1-2):71-84. PubMed ID: 27224007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and characterization of a new peptide vector for short interfering RNA delivery.
    Chen B; Xu W; Pan R; Chen P
    J Nanobiotechnology; 2015 Jun; 13():39. PubMed ID: 26054932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modification of KL4 Peptide Revealed the Importance of Alpha-Helical Structure for Efficient siRNA Delivery.
    Qiu Y; Lo JCK; Kwok KCW; Mason AJ; Lam JKW
    Nucleic Acid Ther; 2021 Jun; 31(3):220-228. PubMed ID: 32352853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Peptide Sequence on Functional siRNA Delivery and Gene Knockdown with Cyclic Amphipathic Peptide Delivery Agents.
    Jagrosse ML; Baliga UK; Jones CW; Russell JJ; García CI; Najar RA; Rahman A; Dean DA; Nilsson BL
    Mol Pharm; 2023 Dec; 20(12):6090-6103. PubMed ID: 37963105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptide-Based Nanoparticles to Rapidly and Efficiently "Wrap 'n Roll" siRNA into Cells.
    Konate K; Dussot M; Aldrian G; Vaissière A; Viguier V; Neira IF; Couillaud F; Vivès E; Boisguerin P; Deshayes S
    Bioconjug Chem; 2019 Mar; 30(3):592-603. PubMed ID: 30586303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular parameters of siRNA--cell penetrating peptide nanocomplexes for efficient cellular delivery.
    van Asbeck AH; Beyerle A; McNeill H; Bovee-Geurts PH; Lindberg S; Verdurmen WP; Hällbrink M; Langel U; Heidenreich O; Brock R
    ACS Nano; 2013 May; 7(5):3797-807. PubMed ID: 23600610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A non-covalent peptide-based strategy for siRNA delivery.
    Crombez L; Divita G
    Methods Mol Biol; 2011; 683():349-60. PubMed ID: 21053142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modification of a designed amphipathic cell-penetrating peptide and its effect on solubility, secondary structure, and uptake efficiency.
    Jafari M; Karunaratne DN; Sweeting CM; Chen P
    Biochemistry; 2013 May; 52(20):3428-35. PubMed ID: 23614788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cationic cell-penetrating peptides as vehicles for siRNA delivery.
    Beloor J; Zeller S; Choi CS; Lee SK; Kumar P
    Ther Deliv; 2015; 6(4):491-507. PubMed ID: 25996046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peptide vectors for the nonviral delivery of nucleic acids.
    Hoyer J; Neundorf I
    Acc Chem Res; 2012 Jul; 45(7):1048-56. PubMed ID: 22455499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous membrane interaction of amphipathic peptide monomers, self-aggregates and cargo complexes detected by fluorescence correlation spectroscopy.
    Vasconcelos L; Lehto T; Madani F; Radoi V; Hällbrink M; Vukojević V; Langel Ü
    Biochim Biophys Acta Biomembr; 2018 Feb; 1860(2):491-504. PubMed ID: 28962904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-covalent Encapsulation of siRNA with Cell-Penetrating Peptides.
    Tuttolomondo M; Ditzel HJ
    Methods Mol Biol; 2021; 2282():353-376. PubMed ID: 33928584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insight into the cellular uptake mechanism of a secondary amphipathic cell-penetrating peptide for siRNA delivery.
    Konate K; Crombez L; Deshayes S; Decaffmeyer M; Thomas A; Brasseur R; Aldrian G; Heitz F; Divita G
    Biochemistry; 2010 Apr; 49(16):3393-402. PubMed ID: 20302329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.